Home Blog Page 1755

Antengene Hosts 2025 R&D Day Showcasing Encouraging Clinical Data and Solid Progress with Investigational Programs

By
Advertorial Desk
-

SHANGHAI and HONG KONG, Nov. 20, 2025 /PRNewswire/ — Antengene Corporation Limited (“Antengene“, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercialising first-in-class and/or best-in-class medicines for autoimmune disease, solid tumors and hematological malignancies indications, announced that at the R&D Day taking place today, it will present the latest data and future plans for three mid/late-stage clinical programs, including ATG-022 (CLDN18.2 antibody-drug conjugate [ADC]), ATG-037 (oral CD73 small molecule inhibitor), and ATG-101 (PD-L1/4-1BB bispecific antibody). The company will also share the latest progress on ATG-125 (B7H3 x PD-L1 bispecific ADC): A B7H3 x PD-L1 targeted therapy featuring “IO + ADC” dual-effect molecules for the treatment of solid tumors and its AnTenGager™ T-cell engager (TCE) technology platform which incorporates steric hindrance masking, along with updates on several key preclinical programs. In addition, guest expert Prof. Xin Wang, Chief Physician, Drug Clinical Trial Center, National Cancer Center / Cancer Hospital of the Chinese Academy of Medical Sciences, will deliver a keynote session sharing her insights on ATG-022.

The event will be held today at 14:00 (Beijing Time), both in-person at the Antengene Shanghai office and online via webcast. For further information on how to join the event, please refer to: https://www.antengene.com/newsinfo/451

1. Building a pipeline of first/best-in-class innovative therapies with strategic focus on four areas

To address major unmet medical needs in the APAC region and globally amid the rapidly evolving innovative drug landscape, Antengene has adopted a forward-looking strategy to build a diverse portfolio covering four major areas – ADCs, immuno-oncology (IO), autoimmune diseases, and TCEs.

  • ADCs: ATG-022 (CLDN18.2 ADC) is advancing smoothly through clinical development and has generated a steady stream of promising data. In addition, two “IO + ADC” dual-mechanism candidates targeting B7-H3 x PD-L1 and CD24 are progressing well in preclinical development.
  • IO: ATG-037 (oral CD73 small molecule inhibitor) and ATG-101 (PD-L1/4-1BB bispecific antibody) are progressing smoothly through clinical studies.
  • Autoimmune diseases: ATG-201 (CD19×CD3 TCE), which is advancing toward clinical studies for the treatment of autoimmune diseases, can mediate complete B cell depletion with reduced risk of cytokine release syndrome (CRS). ATG-207 (undisclosed bifunctional biologics), is a first-in-class preclinical program being developed for T-cell driven autoimmune diseases.
  • TCEs: Antengene has built a robust portfolio of first/best-in-class programs targeting CD19×CD3, CDH6×CD3, ALPPL2×CD3, LY6G6D×CD3, GPRC5D×CD3, LILRB4×CD3, and FLT3×CD3, offering a wide therapeutic window for addressing unmet clinical needs across autoimmune diseases, solid tumors, and hematologic malignancies.

2. Encouraging data set a solid foundation for further advancement in clinical development

▶ ATG-022 (CLDN18.2 ADC)

  • Latest data from the Phase I/II CLINCH study: As of November 10, 2025, in patients with moderate to high CLDN18.2 expression (IHC 2+ > 20%), the 2.4 mg/kg dose cohort achieved an objective response rate (ORR) of 40% (12/30), a disease control rate (DCR) of 90% (27/30), and a median overall survival (mOS) of 14.72 months; while the 1.8 mg/kg dose cohort achieved an ORR of 40% (12/30), a DCR of 86.7% (26/30), and a median progression-free survival (mPFS) of 5.45 months. Among patients with low/ultra-low CLDN18.2 expression (IHC 2+ ≤ 20%), those treated at the efficacious dose range of 1.8-2.4 mg/kg achieved an ORR of 28.6% (6/21) and a DCR of 52.4% (11/21). In these results, ATG-022 demonstrated potent antitumor activity in patients with a broad range of CLDN18.2 expression levels.
  • Broad combinatory potential for front-line treatment: the 1.8 mg/kg cohort demonstrated promising efficacy with only 16.1% of patients experienced grade 3 or higher treatment-related adverse events (TRAEs). This differentiated safety profile uniquely positions ATG-022 as an ADC with best-in-class safety profile and potential to transform first-line standard of care in combination with both immune checkpoint inhibitors (CPIs) and chemotherapy.
  • Three clinical development pathways: To fully realize the therapeutic potential of its CLDN18.2-targeted therapy ATG-022, Antengene has outlined a clear clinical development roadmap designed to achieve regulatory approval, maximize therapeutic reach, and broaden tumor-type coverage. The strategy includes a near-term approval path through a pivotal Phase III in third and later line gastric cancer patients with moderate to high CLDN18.2 expression; a front-line proof-of-concept Phase II study evaluating ATG-022 in combination with a CPI and the CAPOX regimen, which, if supported by positive results, is expected to advance into a Phase III trial; and A broad indication-expansion effort through the ongoing Phase II study that builds on encouraging activity signals, extending beyond gynecologic tumors to further assess ATG-022 across a wider range of solid tumor types.

▶ ATG-037 (oral CD73 small molecule inhibitor)

  • Latest data from the Phase I/Ib STAMINA-01 study: As of October 24, 2025, in the subgroup of patients with CPI-resistant melanoma who received the combination regimen (12 patients), the ORR was 33.3%, the DCR was 100%, including 1 complete response (CR) and 3 partial responses (PRs). One of these patients had maintained CR and reported no safety issues despite having been on the treatment for more than two years. In the subgroup of patients with CPI-resistant non-small cell lung cancer (14 patients), the ORR was 21.4%, the DCR was 71.4%, including 3 PRs. These findings suggest that ATG-037 has clinically meaningful therapeutic potential in multiple tumor types, particularly in patients who are CPI-resistant.
  • Clinical development pathways: existing data show that ATG-037 holds enormous therapeutic potential for the treatment of first-line or CPI-resistant melanoma, with promising potential for expansion into other tumor types. Antengene’s clinical development roadmap for ATG-037 has four main components: 1. combination with CPI for the treatment of CPI-resistant unresectable and metastatic melanoma (second-line treatment); 2. combination with CPI for the first-line treatment of unresectable or metastatic melanoma; 3. active expansion into other tumor types supported by the encouraging proof-of-concept data in CPI-resistant non-small cell lung cancer; 4. explore potential combinations with next-generation CPIs such as PD-1×VEGF bispecific antibody.

▶ ATG-101 (PD-L1/4-1BB bispecific antibody): dose-escalation study of ATG-101 is currently underway in China, the U.S., and Australia, and has already observed favorable safety in varies dosing regimens, thus laying a solid foundation for the future clinical development. One study evaluating ATG-101 in extrapulmonary neuroendocrine carcinoma (EP-NEC) patients will be initiated soon.

3. AnTenGager™ technology platform: a key driver of innovation

▶ A TCE platform featuring steric hindrance masking: AnTenGager™ is a proprietary “2+1” second-generation TCE technology platform featuring “2+1” bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize CRS and enhance efficacy. These characteristics support the platform’s broad applicability across autoimmune diseases, solid tumors and hematological malignancies indications. Leveraging this platform, Antengene has discovered multiple investigational programs:

  • ATG-201 (CD19 x CD3 TCE): ATG-201 is a novel “2+1” CD19-targeted T-cell engager developed on the AnTenGagerTM TCE platform for the treatment of B cell related autoimmune diseases. Preclinical data presented at the 2025 American College of Rheumatology (ACR) Annual Meeting showed that in non-human primate (NHP) models, the monkey surrogate of ATG-201 achieved deep and durable depletion of naïve B cells with a favorable safety profile, characterized by only a very mild and transient increase in cytokine levels. The IND-enabling study of ATG-201 has been completed and the IND-submission is under preparation.
  • ATG-106 (CDH6 x CD3 TCE): A global first-in-class CDH6 x CD3 targeted TCE being developed for the treatment of ovarian cancer and kidney cancer.
  • ATG-110（LY6G6D x CD3 TCE): A potential global best-in-class LY6G6D x CD3 targeted TCE being developed for the treatment of microsatellite stable colorectal cancer.
  • ATG-112 (ALPPL2 x CD3 TCE): A global first-in-class ALPPL2 x CD3 targeted TCE being developed for the treatment of gynecologic tumors and lung cancer.
  • ATG-125 (B7H3 x PD-L1 bispecific ADC): A B7H3 x PD-L1 targeted therapy featuring “IO + ADC” dual-effect molecules for the treatment of solid tumors.
  • ATG-207 (undisclosed bifunctional biologics): a global first-in-class bifunctional biologic agent being developed for the treatment of T-cell driven autoimmune diseases, a therapeutic area representing a huge unmet clinical need.

Antengene will strive to further accelerate these highly promising clinical and preclinical programs. The company plans to report additional progress of these innovative programs and update the medical community, patients, and investors on future developmental milestones at a series of upcoming top international conferences.

About Antengene

Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK) is a global, R&D-driven, commercial-stage biotech company focused on developing first-in-class/best-in-class therapeutics for diseases with significant unmet medical needs. Its pipeline spans from preclinical to commercial stages and includes several in-house discovered programs, including ATG-022 (CLDN18.2 ADC), ATG-037 (oral CD73 inhibitor), ATG-101 (PD-L1 × 4-1BB bispecific antibody), ATG-031 (CD24-targeting macrophage activator), and ATG-042 (oral PRMT5-MTA inhibitor).

Antengene has also developed AnTenGager™, a proprietary T cell engager 2.0 platform featuring “2+1” bivalent binding for low-expressing targets, steric hindrance masking, and proprietary CD3 sequences with fast on/off kinetics to minimize cytokine release syndrome (CRS) and enhance efficacy. These characteristics support the platform’s broad applicability across autoimmune disease, solid tumors and hematological malignancies indications.

To date, Antengene has obtained 31 investigational new drug (IND) approvals in the U.S. and Asia, and submitted new drug applications (NDAs) in 11 Asia Pacific markets. Its lead commercial asset, XPOVIO® (selinexor), is approved in Mainland of China, Taiwan China, Hong Kong China, Macau China, South Korea, Singapore, Malaysia, Thailand, Indonesia and Australia, and has been included in the national insurance schemes in five of these markets (Mainland of China, Taiwan China, Australia, South Korea and Singapore).

Forward-looking statements

The forward-looking statements made in this article relate only to the events or information as of the date on which the statements are made in this article. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. In this article, statements of, or references to, our intentions or those of any of our Directors or our Company are made as of the date of this article. Any of these intentions may alter in light of future development. For a further discussion of these and other factors that could cause future results to differ materially from any forward-looking statement, please see the other risks and uncertainties described in the Company’s Annual Report for the year ended December 31, 2024, and the documents subsequently submitted to the Hong Kong Stock Exchange.

For more information, please contact:

Investor Contacts: 
Donald Lung
E-mail: donald.lung@antengene.com  

BD Contacts:
Ariel Guo
E-mail: ariel.guo@antengene.com 

 

 

Invitation To MCKL Open Day – Every Student’s Degree Pathway Begins Here

By
Advertorial Desk
-

Methodist College Kuala Lumpur (MCKL) invites all high school students, leavers and parents to join the much-anticipated Open Day happening on 21–22 November 2025, from 9:00 a.m. to 5:00 p.m., at both the Kuala Lumpur and Penang (Pykett Campus).


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 20 November 2025 – The event is held in conjunction with MCKL’s Scholarship Week, running from 15–30 November 2025 and it is the perfect opportunity to explore further study options, secure exclusive financial aids, and take the next step toward a successful future.

Highlights of the Open Day include:

  • Career Guidance Test – Discover strengths and career interests to find the right pathway.
  • Personalised Consultation – Meet with MCKL’s academic advisors for one-on-one guidance.
  • Scholarships, Financial Aid & PTPTN Loan – Explore up to 100% merit scholarships and other financial support options.
  • Globally Recognised Programmes – Choose to study at Scottish Qualifications Authority (SQA) approved institutions, opening doors to top universities worldwide.
  • Meet the Lecturers & Campus Tour – Get firsthand experience of MCKL’s vibrant and serene campus life and speak directly with lecturers to learn more about the preferred programme.

Students can take this opportunity to register and apply on the spot, receive exclusive counselling and gain valuable insights into MCKL’s diverse range of programmes that includes Pre-University, Diplomas, American Degree Transfer, Professional Development and more options to explore and discover a seamless pathway towards undergraduate studies.

At Methodist College Kuala Lumpur (MCKL), education goes beyond the classroom. With a strong reputation for academic excellence and holistic development, MCKL continues to empower students to become competent, compassionate and globally minded leaders. MCKL also provide pathways to wide range of degree programmes at globally recognised universities worldwide as well as prestigious local universities, thereby allowing students to progress directly into the second year of their chosen degree.

For over four decades, MCKL has remained committed to its mission of nurturing excellence for life. Whether students aspire to pursue their studies locally or abroad, MCKL provides a solid foundation to help them achieve their goals.

They should not miss out. Mark the calendars and experience how MCKL can shape a student’s academic and personal journey.

To Know More, Make the Appointment Today By:
Calling: KL: 03-2300 0998 | Pg: 04-6888 327
Emailing: KL: admission@mckl.edu.my | PG: admission.pg@mckl.edu.my

And for MCKL Overview, please visit –
Website: www.mckl.edu.my.
Social Media – FB, Instagram, YouTube, Linkedin: @methodistcollegekl

Methodist College Kuala Lumpur (MCKL) looks forward to warmly welcoming students to its campus.

Hashtag: #MCKL #OPENDAY #MethodistCollege #Highereducation #Kualalumpur




The issuer is solely responsible for the content of this announcement.

Methodist College Kuala Lumpur (MCKL)

Methodist College Kuala Lumpur (MCKL) was founded by the Methodist Council of Education in 1983, its campus sitting in the heart of Kuala Lumpur and branch campus in Pykett, Penang, known as the MCKL College (Penang, Pykett Campus). MCKL is now an SQA Approved Centre delivering Advanced Diplomas focusing on Business and Computing: Software Development. It also offers programmes in the pre-university pathway for subjects including Cambridge A-Level, Australian Matriculation; the American Degree Transfer, Diploma courses Digital Business, Digital Marketing, IT (Internet of Things Focused), Computer Science (data science focused), Early Childhood Education, Social Work, and Financial Technology. Over the years, MCKL has been highly recognised for its track record and gold standard achievements of its pre-university programmes and its overseas degree pathways.

For additional information, please visit the .

Taiwan CareTech Alliance Targets Japan’s Silver Market with Smart Elderly Care Solutions

By
Advertorial Desk
-

TAIPEI, TAIWAN – Media OutReach Newswire – 20 November 2025 – To seize opportunities in Japan’s rapidly aging market, Taiwan’s smart assistive technology SME, Netown Corporation, has partnered with nine outstanding care technology Taiwanese SMEs to establish the Taiwan CareTech Alliance (Japanese name: 台湾ケアテック連盟). Under this brand, the alliance aims to expand into Japan’s growing silver economy, showcasing Taiwan’s capabilities in smart elderly care solutions.

Taiwan CareTech Alliance Targets Japan’s Silver Market with Smart Elderly Care Solutions

To build a more comprehensive long-term care technology ecosystem, the alliance has introduced two innovative integrated products: “Smart Nursing Bed” and “Smart Group Trainer.” These products combine AI-driven health monitoring, support, and interactive functions, ushering in a new era of intelligent elderly care.

To strengthen its international reach, the alliance has launched a series of short promotional videos, an official website, and multi-platform social media channels (including LinkedIn and X/Twitter) to highlight Taiwan’s strengths in integrated assistive technologies. The alliance also participated in major Japanese exhibitions—the Japan Health Expo in Osaka and Medical Japan Tokyo 2025—engaging with over 3,000 visitors, including local short- and long-term care facilities and medical distributors, showcasing its new integrated products.

Furthermore, the alliance has actively collaborated with Japan’s Kyushu Medical Equipment Group Federation and the Japan Overseas Medical Equipment Technical Assistants, gaining strong recognition and support from local organizations. With support from the Taiwanese government, the Taiwan CareTech Alliance is developing smart elderly care and aging-care solutions while expanding the global presence and business potential of MIT (Made in Taiwan) assistive devices in Japan and other international markets.

The issuer is solely responsible for the content of this announcement.

2Africa Submarine Cable’s Core Infrastructure Completed China Mobile International Advances Africa’s Digital Intelligence Development

By
Advertorial Desk
-

HONG KONG, Nov. 20, 2025 /PRNewswire/ — China Mobile International Limited (CMI), along with seven global partners including Bayobab, center3, Meta, Orange, Telecom Egypt, Vodafone Group, and WIOCC, has jointly completed the core 2Africa Submarine Cable Infrastructure (2Africa). Circling the African continent and connecting intercontinental nodes across Europe, Asia, and beyond, the 2Africa will further expand CMI’s global submarine cable layout and international connectivity resources, providing a robust digital infrastructure to accelerate the digital economic development in Africa and the surrounding regions.

2Africa Submarine Cable’s Core Infrastructure Completed.
2Africa Submarine Cable’s Core Infrastructure Completed.

As the first cable to continuously link Africa’s east and west within a single system, 2Africa adopts an open-access model. Spanning over 45,000 kilometers, it connects 33 + countries / regions across Africa, the Middle East, Europe, and Asia, with a design capacity of 180Tbps. According to estimates, 2Africa is projected to contribute up to USD36.9 billion to Africa’s GDP within the first two to three years of operation.

Following the commissioning of the 2Africa’s key segments, CMI has further optimized resource allocation along the Arabian Sea, the eastern and western coasts of Africa, and Europe. It has also created synergies with high-capacity submarine cables along the eastern and western coasts of Africa such as PEACE and Equiano, enabling CMI to enhance the multi-ring network covering Africa. Leveraging global network resources in Djibouti, Tanzania, Kenya, South Africa, Nigeria, and other locations, as well as submarine cable systems such as IAX-IEX, 2Africa integrates Eurasia-Africa’s high-capacity bandwidth with extensions of local terrestrial cable and PoP. This initiative aims to build a leading regional international submarine cable connectivity that covers Africa while extending its influence to Asia-Pacific and Europe.

CMI leverages 2Africa’s technical advantages of “high-bandwidth and low-latency” to form powerful synergies with the company’s existing cloud-network capabilities, including over 100 submarine and terrestrial cables, 380+PoPs, and 1,270+ data centers worldwide. This robust infrastructure allows CMI to provide global carrier customers with high-quality international private lines, cloud private lines, and interconnection services covering multiple core cities in Africa and extending to the African interior. Together with the mCloud cloud-network integration portal with a one-stop integrated package featuring “a unified platform, one country, one price, one-click ordering, and end-to-end services,” CMI offers AI+ cloud-network integration solutions for enterprises to step into Africa and the Middle East markets, as well as local partners. These solutions focus on key African industries, such as AI+ Smart Energy Mining and AI+ Smart Park, driving the region toward an AI-powered digital intelligence future.

CMI has been tapping into the African market since 2015. The completion of the core 2Africa submarine cable infrastructure will further enrich network resources in the African region, delivering high-quality, reliable connectivity to critical sectors such as education, healthcare, and financial services, thereby accelerating Africa’s digital transformation and improving the lives of communities across the continent.

Looking ahead, CMI will continue to leverage submarine cable projects such as the 2Africa to accelerate the implementation of new information infrastructure and new information service system in Africa, contributing digital and intelligent solutions to the continent and comprehensively supporting the vigorous development of Africa’s digital economy.

2Africa Submarine Cable’s Core Infrastructure Completed.
2Africa Submarine Cable’s Core Infrastructure Completed.

2Africa Submarine Cable’s Core Infrastructure Completed.
2Africa Submarine Cable’s Core Infrastructure Completed.

Cebu Pacific Named Strongest Asean Airline Brand by Brand Finance

By
Advertorial Desk
-

MANILA, Philippines, Nov. 20, 2025 /PRNewswire/ — Cebu Pacific (PSE: CEB), the Philippines’ leading carrier, has been recognized by Brand Finance as the strongest airline brand in the ASEAN region, underscoring the airline’s growing resonance with travelers and its reputation for value, reliability, and innovation.

Cebu Pacific Chief Marketing and Customer Experience Officer Candice Iyog (R) receives the award for ASEAN's Strongest Airline Brand from Brand Finance Managing Director for Asia Pacific Alex Haigh (L).
Cebu Pacific Chief Marketing and Customer Experience Officer Candice Iyog (R) receives the award for ASEAN’s Strongest Airline Brand from Brand Finance Managing Director for Asia Pacific Alex Haigh (L).

The award reflects Cebu Pacific’s consistent efforts to make air travel more accessible while strengthening customer trust and loyalty through service improvements, digital transformation, and community engagement.

“Being named the strongest airline brand in ASEAN reminds us that our strength comes from our people. We are grateful to our pilots, cabin crew, ground operations, customer care teams, and colleagues across the business who work tirelessly to serve our passengers with care and professionalism. Their collective efforts have strengthened our brand and earned the trust of millions of travelers across the region,” said Candice Iyog, Cebu Pacific Chief Marketing and Customer Care Officer who personally received the award.

“We are honored by the trust given to us, and we remain committed to making travel easier, friendlier, and more accessible for Filipinos and travelers across the region.”

The recognition comes from Brand Finance’s latest valuation study, which provides a holistic view of brand strength by combining consumer perception and financial analysis. Drawing insights from 175,000 respondents across 41 countries, including 25,000 from the Asia Pacific region, the study measures awareness, consideration, and reputation across 31 sectors, covering 6,000 brands with nine years of data.

Cebu Pacific achieved an AAA brand rating and a Brand Strength Index (BSI) score of 86.1. It also recorded an 86% increase in brand value to US$386 million this year from 2024.

“Being the strongest airline brand in ASEAN means Cebu Pacific leads the region in these critical drivers of brand equity, outperforming competitors in both customer perception and operational reputation. This strength translates into greater resilience, and long-term growth potential. It reinforces Cebu Pacific’s strong position in the airline sector and the impact of its brand, marketing, and customer initiatives,” said Alex Haigh, Managing Director at Brand Finance Asia Pacific.

Cebu Pacific entered the aviation industry on March 1996 and pioneered the “low fare, great value” strategy and has flown over 250 million passengers since inception. CEB offers the widest domestic network in the Philippines with 37 domestic and 26 international destinations, spanning across Asia, Australia, and the Middle East.

Brand Finance is the world’s leading brand valuation consultancy. Bridging the gap between marketing and finance, Brand Finance evaluates the strength of brands and quantifies their financial value to help organizations make strategic decisions. Headquartered in London, Brand Finance operates in over 25 countries. Every year, Brand Finance conducts more than 6,000 brand valuations, supported by original market research, and publishes over 100 reports which rank brands across all sectors and countries.

Our social media handles:

Facebook: Cebu Pacific Air
X: @CebuPacificAir
Instagram: cebupacificair

SATS Posts 2Q Net Profit Of S$78.9 Million

By
Advertorial Desk
-

2Q FY26 Highlights (YoY):

  • Revenue rose 8.4% to S$1.6B, driven by strong cargo volume growth across Asia, Europe and the Middle East
  • EBITDA grew 15.7% to S$307.4M with margin expansion from 18.3% to 19.6%
  • SATS declares an interim dividend of 2 cents (S$) per share

SINGAPORE – Media OutReach Newswire – 20 November 2025 – SATS Ltd (SATS or the Company and together with its subsidiaries, the Group) today reported its financial performance for the three months ended 30 September 2025 (2Q FY26).

SATS Cargo Handling

HIGHLIGHTS OF THE GROUP’S UNAUDITED RESULTS:

Group Financial Results 2Q FY26

(S$ million) 		2Q FY25

(S$ million)

Favourable / (Unfavourable) YoY Change (S$ million) Favourable / (Unfavourable) YoY Change (%)
Revenue 1,572.1 1,450.7 121.4 8.4
Operating expenditure (excluding D&A) (1,264.7) (1,185.0) (79.7) (6.7)
EBITDA

EBITDA margin

307.4

19.6%

265.7

18.3%

41.7

1.3ppt

15.7
Operating profit (EBIT)

EBIT margin

157.4

10.0%

127.2

8.8%

30.2

1.2ppt

23.7
SoAJV 27.5 29.7 (2.2) (7.5)
Profit attributable to owners of the Company (PATMI) 78.9 69.7 9.2 13.3
Group Financial Results YTD FY26

(S$ million)

YTD FY25

(S$ million)

Favourable / (Unfavourable) YoY Change (S$ million) Favourable / (Unfavourable) YoY Change (%)
Revenue 3,078.5 2,821.1 257.4 9.1
Operating expenditure (excluding D&A) (2,497.3) (2,306.3) (191.0) (8.3)
EBITDA

EBITDA margin

581.2

18.9%

514.8

18.2%

66.4

0.7ppt

12.9
Operating profit (EBIT)

EBIT margin

282.6

9.2%

240.1

8.5%

42.5

0.7ppt

17.7
SoAJV 60.6 65.3 (4.7) (7.3)
Profit attributable to owners of the Company (PATMI) 149.8 134.7 15.1 11.2

Notes:
(1) FY26 refers to the financial year from 1 April 2025 to 31 March 2026
(2) D&A refers to depreciation and amortisation
(3) EBITDA refers to earnings before interest, tax, depreciation and amortisation
(4) SoAJV refers to the share of associates/joint ventures, net of tax

GROUP EARNINGS

2Q FY26 (1 July 2025 to 30 September 2025)

Amid continued volatility to global trade flows, SATS Group achieved 2Q FY26 revenue of S$1.57 billion, an increase of 8.4% compared to the same period last year. The Group attributes this to strong cargo performance alongside steady contributions from ground handling and food services.

Gateway Services revenue rose 10.7% year-on-year to S$1.22 billion, driven by continued market share gains with cargo volumes that outperformed IATA’s global growth benchmarks.

Food Solutions revenue grew 1.0% year-on-year to S$356.5 million, reflecting stable inflight meal demand amid air travel expansion in Asia-Pacific. Growth was modest as the prior year period benefited from catch-up pricing adjustments.

The Group’s expenditure (excluding depreciation and amortisation) increased 6.7% year-on-year to S$1.26 billion.

Operating profit for 2Q FY26 rose 23.7% year-on-year to S$157.4 million, with operating profit margin expanding to 10.0% from 8.8% in the prior year. This improvement reflects favourable operating leverage from volume growth and continued operational efficiency gains.

The share of earnings from associates and joint ventures decreased 7.5% to S$27.5 million year-on-year, due to ramp-up costs associated with new customer onboarding in a joint venture.

The Group posted PATMI of S$78.9 million, an increase of 13.3% over 2Q FY25.

1H FY26 (1 Apr 2025 to 30 September 2025)

SATS Group achieved revenue of S$3.08 billion, an increase of 9.1% compared to the same period last year. Strong cargo volume growth along with contributions from ground handling and food services contributed to the Group’s performance.

The Group’s expenditure (excluding depreciation and amortisation) increased 8.3% year-on-year to S$2.50 billion.

Operating profit rose 17.7% year-on-year to S$282.6 million, with operating profit margin expanding to 9.2% from 8.5%, reflecting the Group’s focus on operational efficiency.

The share of earnings from associates and joint ventures decreased 7.3% to S$60.6 million year-on-year, primarily due to a one-off net gain recognised in the prior-year period and ramp-up costs associated with new customer onboarding in a joint venture.

The Group posted PATMI of S$149.8 million, an increase of 11.2%.

GROUP FINANCIAL POSITION (as at 30 September 2025)

Total equity increased by S$134.0 million, reaching S$2.90 billion as of 30 September 2025, compared to 31 March 2025. This increase was primarily attributed to the profit generated in the half year ended 30 September 2025.

As of 30 September 2025, total assets stood at S$8.89 billion, an increase of S$5.5 million from 31 March 2025. Total liabilities decreased by S$128.5 million from 31 March 2025 to S$5.99 billion, due mainly to lower trade and other payables and the repayment of S$100 million in Singapore dollar Medium Term Notes (SGD MTN) in April 2025.

Operating cash flow after lease repayment for YTD FY26 was S$123.0 million, an increase of S$80.1 million from prior year, underpinned by stronger operational performance and working capital management. YTD FY26 free cash flow1 was negative S$1.1 million, compared to negative S$52.8 million in the prior year.

1 Free cash flow refers to net cash from operating activities less capex and lease payment. FY25 cash flow from operating activities and investing activities were restated due to reclassification of interest income/expense

INTERIM DIVIDEND

In view of the Group’s financial performance in 1H FY26, the Board of Directors has declared an interim dividend of 2 cents (S$) per share, payable on 5 December 2025. The book closure date is 24 November 2025.

OUTLOOK

Our second quarter performance was resilient amid evolving market conditions. Gateway Services continues to demonstrate strength, leveraging its broad customer base and network scale, while Food Solutions is positioned to capture stable meal demand across the region.

SATS has outperformed IATA benchmarks over the past eight consecutive quarters, though second quarter volumes reflected in part accelerated customer shipments ahead of tariff implementations. As trade patterns continue to adjust to changing policies, we remain focused on adapting operations across our network to manage volume shifts while maintaining operational discipline.

Our network continues to support market share gains, and Americas and EMEAA are expanding specialised capabilities to capture e-commerce and freight forwarder volumes. Recent developments include the opening of a new E-Commerce and Freight Forwarder Handling facility at Copenhagen Airport, and the renewal of an Air China Cargo contract in Liège, reinforcing our position in key European hubs and e-commerce corridors. In 2Q FY26, we onboarded and ramped-up operations for several new customers, including Emirates SkyCargo and eDirect Transport at Frankfurt Cargo Services and Turkish Airlines at JFK Airport’s Building 260.

In Singapore, the Group continues to strengthen its role as the anchor of SATS’ global network. The newly announced Hub Handler of the Future programme will reimagine air hub operations through automation and workforce innovation, supporting Changi’s long-term competitiveness. Beyond aviation, Marina Bay Cruise Centre Singapore, managed by SATS-Creuers Cruise Services, has completed a S$40 million upgrade to accommodate dual-ship calls and enhance passenger experience. Together, these initiatives underscore SATS’ commitment to advancing Singapore as a world-class hub for trade and travel.

Looking ahead, we will continue to prioritise operational efficiency and disciplined cost management amid continued uncertainty in global trade flows. Leveraging our global network advantage, we are well-positioned to drive profitable growth.

Kerry Mok, SATS President and Chief Executive Officer, said, “SATS’ second quarter results were enabled by a global network and consistent execution across our operations. While volumes were strong, we recognise that the quarter benefited in part from front-loading ahead of tariff changes. We are actively managing our capacity and resources as demand patterns evolve.

“We continue to work closely with our key customers and are investing in specialised handling capabilities to support their growth.

“Closer to home, Singapore remains at the heart of our network and multi-year transformational journey. We are building the foundation for next-generation mega air hubs that bring together technology, innovation and people to shape the future of travel and logistics. These upgrades to Singapore’s air and sea gateway infrastructure reinforce our role in enhancing Singapore’s global connectivity.

“Our first-half performance demonstrates the resilience of our diversified platform and the effectiveness of our network operational approach. We remain committed to delivering value through disciplined execution and strategic focus as we navigate the quarters ahead.”

ANNEX A: GROUP FINANCIAL STATISTICS

Financial Results (S$) 2Q FY26 2Q FY25 1H FY26 1H FY25
Per Share Data
Earnings per share (cents)
– Basic R1 5.3 4.7 10.1 9.1
– Diluted R2 5.2 4.6 9.9 9.0
Return on turnover (%) R3 5.0 4.8 4.9 4.8

As at As at
Financial Position (S$ million) 30 Sep 2025 31 Mar 2025
Total equity 2,902.9 2,768.9
Total assets 8,888.2 8,882.7
Total debt 4,194.0 4,244.1
Gross debt/equity ratio (times) R4 1.44 1.53
Net asset value per share (S$) R5 1.81 1.74

Notes:
The Group financial statistics should be read in conjunction with the explanatory notes found on page 2 of this media release.

R1 Earnings per share (basic) is computed by dividing profit attributable to owners of the Company by the weighted average number of fully paid shares in issue.
R2 Earnings per share (diluted) is computed by dividing profit attributable to owners of the Company by the weighted average number of fully paid shares in issue after adjusting for dilution of shares under various employee share plans.
R3 Return on turnover is computed by dividing profit attributable to owners of the Company by total revenue.
R4 Gross debt/equity ratio is computed by dividing total debt by total equity.
R5 Net asset value per share is computed by dividing equity attributable to owners of the Company by the number of ordinary shares (excluding treasury shares) in issue.

ANNEX B: OPERATING STATISTICS

2Q FY26 1Q FY26 QoQ (%) 2Q FY25 YoY (%)
Flights Handled (‘000) 160.6 158.8 1.2 160.8 -0.1
– APAC 88.7 87.7 1.2 82.8 7.2
– EMEAA 3.6 3.4 5.3 8.2 -56.2
– Americas 68.3 67.7 0.9 69.8 -2.1
Cargo Processed (‘000 tonnes) 2,381.9 2,379.3 0.1 2,223.1 7.1
– APAC 726.0 704.0 3.1 678.4 7.0
– EMEAA 1,021.1 999.4 2.2 855.7 19.3
– Americas 634.8 675.9 -6.1 689.1 -7.9
Gross Meals Produced (‘M) 29.3 26.1 12.4 28.9 1.4
– Aviation meals 17.6 16.4 7.4 17.4 0.9
– Non-aviation meals 11.7 9.7 20.6 11.5 2.1
Ship Calls Handled 40 48 -16.7 45 -11.1

Notes:
i. Reduction in flights handled volume in EMEAA mainly due to disposal of ground handling business in UK.
ii. The above operating data cover SATS and its subsidiaries, but does not include joint ventures and associates.

Hashtag: #SATS

The issuer is solely responsible for the content of this announcement.

SATS LTD.

Headquartered in Singapore, SATS Ltd. (SGX stock code: S58) is one of the world’s largest providers of air cargo handling services and Asia’s leading airline caterer. SATS Gateway Services provides airfreight and ground handling services including passenger services, ramp and baggage handling, aviation security services, aircraft cleaning and aviation laundry. SATS Food Solutions serves airlines and institutions, and operates central kitchens with large-scale food production and distribution capabilities for a wide range of cuisines. SATS is present in the Asia-Pacific, the Americas, Europe, the Middle East and Africa, powering an interconnected world of trade, travel and taste. Following the acquisition of Worldwide Flight Services (WFS) in 2023, the combined SATS and WFS network operates over 225 stations in 27 countries. These cover trade routes responsible for more than 50% of global air cargo volume. SATS has been listed on the Singapore Exchange since May 2000. For more information, please visit

A Decade of Connecting Perth and Malaysia with Batik Air

By
Advertorial Desk
-

Celebrating 10 Years of Seamless Connectivity, Enhanced Travel Options, and Growing Tourism Ties

PERTH, AUSTRALIA – Media OutReach Newswire – 20 November 2025 – Batik Air Malaysia proudly celebrates 10 years of connecting Perth and Malaysia, marking a decade of reliable and convenient travel with special festivities at Perth Airport, Australia.

This milestone reflects the airline’s ongoing commitment to providing passengers with a smooth and enjoyable travel experience while strengthening Perth’s links to Malaysia and the wider region.

To mark this landmark anniversary, Batik Air has planned a series of engaging activations at Perth Airport including commemorative displays, exclusive giveaways, and special surprises for passengers throughout the day.

In conjunction with the celebrations, Batik Air is also offering passengers a limited-time promotional voucher, valid for 72 hours. The FLYBATIKAIR promo code will be available from 19 November 2025, with immediate validity for use.

Promo Offer:
Economy Value Fare – 10% off
Economy Flexi Fare – 15% off
Booking Period: 19–21 November 2025
Travel Period: 19 November 2025 – 30 March 2026 (blackout dates apply)

Passengers are invited to join the celebrations at Perth Airport and take advantage of the exclusive promotional offers as Batik Air marks this milestone anniversary.

Perth Airport’s Acting Chief Commercial & Aviation Officer James Gorton said our long-standing partnership with Batik Air has connected Western Australia to Malaysia for the past decade. At the time, Perth was the airline group’s first entry-point into the Australian market.

“Over the past 10 years, Perth Airport and Batik Air have maintained a strong partnership that has contributed to Malaysia becoming Western Australia’s fifth largest international visitor market, injecting $131 million into the WA economy in visitor expenditure in FY25.

“We congratulate Batik Air on this is significant milestone and we look forward to future decades of our successful partnership and convenient travel options for customers at Perth Airport.”

Batik Air Chief Executive Officer, Datuk Chandran Rama Muthy said: “Ten years on, this route continues to demonstrate the strength of air connectivity in creating opportunities and deepening ties across the region. This milestone marks both a proud achievement and the beginning of a new chapter for Batik Air.”

“As we look ahead, our focus is on developing a smarter, more connected network that offers travellers greater choice, comfort, and consistency. The decade ahead will be shaped by innovation, resilience, and a clear ambition to enhance the travel experience while strengthening Malaysia’s role as an important aviation gateway,” he added.

At present, Batik Air operates seven weekly direct flights between Perth and Kuala Lumpur, alongside seven weekly one-stop services to Denpasar, Bali, offering travellers a mix of convenient and flexible options to suit different journey preferences. This well-established schedule has supported strong two-way traffic over the years, connecting families, students, business travellers, and holidaymakers across both markets.

In response to the steady rise in passenger demand and the growing appeal of Perth as a leisure and business destination, Batik Air will be operating additional 11x direct flights in December 2025. This enhancement underscores the airline’s commitment to supporting two-way traffic, stimulating tourism, and facilitating smoother travel flows for the region.

For more information and to plan your next journey, download Batik Air mobile app or visit www.batikair.com

Hashtag: #BatikAirMalaysia #BatikAir #LionGroup #iflybatikair #Perth #Australia #PerthAirport





The issuer is solely responsible for the content of this announcement.

Batik Air Malaysia

Batik Air is a rapidly expanding Malaysian carrier with its main hub at Kuala Lumpur International Airport, Sepang and Sultan Abdul Aziz Shah Airport, Subang. The airline took to the skies in March 2013 with domestic flights in Malaysia and has since grown to operate routes to all major airports across the continents of Asia, Australia, Middle East and Central Asia.

Batik Air fleet includes six A330-300 aircraft and forty-six B737-8/800 aircraft. With an extensive network of 1,400 weekly flights, Batik Air offers seamless connections to over 60+ destinations across 20 countries. Batik Air carried a total of 4.5 million passengers in 2023 and 6.6 million passengers in 2024.

The airline holds full membership in the International Air Transport Association (IATA), and also obtained the IATA Operational Safety Audit (IOSA). Batik Air operates under the Lion Air Group of Indonesia, which includes Batik Air Indonesia, Super Air Jet, Lion Air, Wings Air, Biz Jet, and Thai Lion Air.

“TORI SANWA,” Japan’s Century-Old Legendary Brand, Collaborates with Café Sensu for a Pop-up Store Launch at Tai Koo APITA

By
Advertorial Desk
-

HONG KONG SAR – Media OutReach Newswire – 20 November 2025 – With over 125 years of history in Japan, the legendary Japanese brand revered as the “King of Purebred Chicken”, “TORI SANWA,” has seen continuous high popularity and enthusiastic response since its launch in Times Square, Causeway Bay. To meet the fervent anticipation of its broad customer base, TORI SANWA is collaborating with family style Café Sensu as a Pop-up Store at APITA in Cityplaza Tai Koo, starting from November 18, 2025. This Pop-up Store not only brings great news to Tai Koo neigborhoods but also offers a healthy and convenient new dining option for nearby business professionals and office workers. To celebrate, they also feature a flash surprise offer that is only in Taikoo.

Tori Sanwa X SENSU

Exquisite Purebred Nagoya Cochin Chicken: Directly Sourced from Nagoya

The essence of the TORI SANWA brand lies in its unwavering commitment to the legendary ingredient—the purebred Nagoya Cochin chicken. This precious breed boasts a history dating back to the Edo period in 1822. Through two centuries of lineage control, the brand proudly maintains a standard of 100% purebred cultivation. The rarity of this chicken is comparable to Wagyu beef in the meat market. In fact, Nagoya Cochin chicken accounts for only 0.14% of all chickens in Japan, making it extremely scarce.

Compared to ordinary broilers, the Nagoya Cochin requires a lengthy growth period of 125 days – nearly 3 times longer – and incurs 5 times the rearing cost. This extended nurturing results in meat thatis firm with a good bite, possesses pure umami flavor, and is rich in high protein, low fat, and collagen. TORI SANWA is uncompromising on quality, with all raw ingredients, including the chicken and the rich bone broth essence that directly from Nagoya to Hong Kong.

From Classic Donburi to Local Mizutaki Pot: Showcasing the Potential of Nagoya Cochin Chicken

TORI SANWA’s signature Oyakodon has achieved a remarkable milestone, with over one billion bowls in global sales, drawing countless epicures. This pop-up at Taikoo will prominently feature the brand’s masterpiece: the Tokujo Nagoya Cochin Oyakodon (Parent-Child Donburi Nagoya Cochin Chicken) (HK$118). This dish upholds a century-old tradition from the Edo period, faithfully adhering to the secret recipe established in 1900. Its secret sauce is crafted from an exclusive seafood broth, with the special addition of the essence of Nagoya Cochin chicken bone broth, creating layers of double umami. To distill the broth’s flavor to perfection, Tori Sanwa has consciously avoided common ingredients like onions, allowing the purity of the chicken and sauce to shine. Topped with rigorously sourced, sashimi-grade egg liquid, the dish beautifully melds with the tender, flavorful chicken, perfectly embodying the fusion of tradition and craftsmanship.

In addition, TORI SANWA presents the “Gozen Set Menu” series, featuring a main chicken dish accompanied by a small portion of Oyakodon, inviting guests on a multi-sensory journey to experience various chicken cooking methods in one exquisite meal. The Teriyaki Chicken Cutlet Meal (HK$118) features tender chicken that is expertly pan-seared and coated with a signature sauce, resulting in an irresistible flavor. Meanwhile, the Karaage Chicken Meal (HK$118) boasts a crispy exterior that locks in the juices, offering a delightful textural contrast. To further elevate the dining experience, guests can enhance their meal with rich and flavorful side dishes, such as Chicken Skewers (HK$28 for 2 sticks), Karaage Fried Chicken (starting from HK$42), and Fried Chicken Wings (starting from HK$48), adding extra layers of enjoyment to the palate. Additionally, TORI SANWA is also newly introducing two Donburi rice bowls. The new Oyakodon series includes seafood-infused options, such as the Giant Clams and Asparagus Cochin Chicken Oyako Don (HK$118) and the Toyama White Shrimp Cochin Chicken Oyako Don (HK$138), offering rich, layered textures.

Catering to the Premium Island East Community: Presenting Healthy Gourmet Washoku for Families

The area surrounding Cityplaza in Tai Koo is a prestigious residential district in Island East, home to a vibrant community of families and business professionals. TORI SANWA recognizes the strong demand here for high-quality, healthy Japanese cuisine. The Nagoya Cochin chicken , know for is rich in high protein, low fat, and collagen, providing healthy and nourishing meals for the entire family. As a Japanese national favorite, Oyakodon serves as both a quick, convenient lunch and a premium family dinner option, offering residents and nearby business professionals a supreme culinary experience from the first bite to the heart.

Limited-Time Flash Surprise!

To celebrate the launching of the TORI SANWA Pop-up Store at APITA, Tai Koo, we are excited to offer a limited-time flash discount promotion. Customers who spend a designated amount at APITA will receive a $10 cash voucher, redeemable immediately for dine-in orders at the TORI SANWA Pop-up Store, providing customers with an extra-valued Washoku experience.

Hashtag: #TORISANWA

The issuer is solely responsible for the content of this announcement.

About TORI SANWA

Founded in 1900, TORI SANWA is one of Japan’s most historic and highly regarded chicken brands. The brand is dedicated to utilizing the rare purebred Nagoya Cochin chicken in its cuisine, with all ingredients meticulously raised and directly supplied by its own farms. Through its extreme attention to ingredients and unwavering adherence to tradition, TORI SANWA is beloved by local Japanese diners and has successfully expanded into international markets, including Taiwan and Singapore. Its launch in Hong Kong presents an opportunity for local diners to savor the exceptional flavors of chicken cuisine honed through a century of craftsmanship.

Address：Shop TKS-02, G/F, Apita, Cityplaza, 18 Taikoo Shing Road, Tai Koo
Operating Hours ：Monday to Friday: 12:00 PM to 10:00 PM
Saturday, Sunday, and public holiday : 11:30 AM to 10:00 PM
Phone：+852 2166 1159

Email：
Website：
Facebook：
Instagram：

1...1,7541,7551,756...6,466Page 1,755 of 6,466